Literature DB >> 17641225

Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.

Ganapati H Mahabeleshwar1, Weiyi Feng, Kumar Reddy, Edward F Plow, Tatiana V Byzova.   

Abstract

The functional responses of endothelial cells are dependent on signaling from peptide growth factors and the cellular adhesion receptors, integrins. These include cell adhesion, migration, and proliferation, which, in turn, are essential for more complex processes such as formation of the endothelial tube network during angiogenesis. This study identifies the molecular requirements for the cross-activation between beta3 integrin and tyrosine kinase receptor 2 for vascular endothelial growth factor (VEGF) receptor (VEGFR-2) on endothelium. The relationship between VEGFR-2 and beta3 integrin appears to be synergistic, because VEGFR-2 activation induces beta3 integrin tyrosine phosphorylation, which, in turn, is crucial for VEGF-induced tyrosine phosphorylation of VEGFR-2. We demonstrate here that adhesion- and growth factor-induced beta3 integrin tyrosine phosphorylation are directly mediated by c-Src. VEGF-stimulated recruitment and activation of c-Src and subsequent beta3 integrin tyrosine phosphorylation are critical for interaction between VEGFR-2 and beta3 integrin. Moreover, c-Src mediates growth factor-induced beta3 integrin activation, ligand binding, beta3 integrin-dependent cell adhesion, directional migration of endothelial cells, and initiation of angiogenic programming in endothelial cells. Thus, the present study determines the molecular mechanisms and consequences of the synergism between 2 cell surface receptor systems, growth factor receptor and integrins, and opens new avenues for the development of pro- and antiangiogenic strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641225      PMCID: PMC2723825          DOI: 10.1161/CIRCRESAHA.107.155655

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  28 in total

Review 1.  Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesis.

Authors:  C C Kumar; L Armstrong; Z Yin; M Malkowski; E Maxwell; H Ling; B Yaremko; M Liu; J Varner; E M Smith; B Neustadt; T Nechuta
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

2.  Integrin indecision.

Authors:  Peter Carmeliet
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

3.  Phosphorylation of beta3 integrin controls ligand binding strength.

Authors:  Anirban Datta; Francois Huber; David Boettiger
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

4.  Endothelial integrins and angiogenesis: not so simple anymore.

Authors:  Dean Sheppard
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 5.  Interactions between growth factor receptors and adhesion molecules: breaking the rules.

Authors:  Paolo M Comoglio; Carla Boccaccio; Livio Trusolino
Journal:  Curr Opin Cell Biol       Date:  2003-10       Impact factor: 8.382

Review 6.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

Review 7.  Vascular integrins in tumor angiogenesis: mediators and therapeutic targets.

Authors:  Gian Carlo Alghisi; Curzio Rüegg
Journal:  Endothelium       Date:  2006 Mar-Apr

Review 8.  Integrins: molecular targets in cancer therapy.

Authors:  Gordon C Tucker
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

Review 9.  Integrin and growth factor receptor crosstalk.

Authors:  B P Eliceiri
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

10.  Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

Authors:  J C Gutheil; T N Campbell; P R Pierce; J D Watkins; W D Huse; D J Bodkin; D A Cheresh
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

View more
  121 in total

1.  Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.

Authors:  Sribalaji Lakshmikanthan; Magdalena Sobczak; Changzoon Chun; Angela Henschel; Jillian Dargatz; Ramani Ramchandran; Magdalena Chrzanowska-Wodnicka
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane.

Authors:  Lea Scheppke; Eric A Murphy; Alessandro Zarpellon; Jennifer J Hofmann; Alona Merkulova; David J Shields; Sara M Weis; Tatiana V Byzova; Zaverio M Ruggeri; M Luisa Iruela-Arispe; David A Cheresh
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

3.  The adaptor protein Shc integrates growth factor and ECM signaling during postnatal angiogenesis.

Authors:  Daniel Timothy Sweet; Zhongming Chen; David M Wiley; Victoria L Bautch; Ellie Tzima
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

4.  Differential effects of a soluble or immobilized VEGFR-binding peptide.

Authors:  Justin T Koepsel; Eric H Nguyen; William L Murphy
Journal:  Integr Biol (Camb)       Date:  2012-06-25       Impact factor: 2.192

Review 5.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

6.  Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.

Authors:  Saji Oommen; Shiv K Gupta; Nicholas E Vlahakis
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

Review 7.  Tumor angiogenesis: molecular pathways and therapeutic targets.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

8.  Anti-angiogenic effects of non-peptide integrin alphavbeta3 specific antagonist on laser-induced choroidal neovascularization in mice.

Authors:  Shigeru Honda; Takayuki Nagai; Akira Negi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-02       Impact factor: 3.117

Review 9.  Effects of integrins and integrin αvβ3 inhibitor on angiogenesis in cerebral ischemic stroke.

Authors:  Jia-Jia Bi; Li Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

10.  Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma.

Authors:  Shu-Guang Li; Zai-Yuan Ye; Zhong-Sheng Zhao; Hou-Quan Tao; Yuan-Yu Wang; Chun-Yu Niu
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.